Virpax Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2022 to 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Virpax Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2022 to 2023.
Virpax Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $8.13K, a 93.6% decline year-over-year.
Virpax Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $500K, a 157% increase from 2022.

Nonoperating Income (Expense), Annual (USD)

Nonoperating Income (Expense), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$500K	+$306K	+157%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-26
2022	$194K			Jan 1, 2022	Dec 31, 2022	10-K	2024-03-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.